GLIA Diagnostics
  • Home
  • Concussion
    • Concussion
  • Cost of TBI
  • Sport
  • Military
    • Military
    • PTSD
    • Blast Overpressure
  • Clinical Tools
    • Observational Tools
    • Imaging
    • Neurocognitive
  • Biomarkers 1
  • Biomarkers 2
  • microRNA
  • Neurodegenerative Dx
    • Neuro Dx
    • Our Staff
    • Contact Us
    • Blog
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

GLIA Diagnostics

Signed in as:

filler@godaddy.com

  • Home
  • Concussion
    • Concussion
  • Cost of TBI
  • Sport
  • Military
    • Military
    • PTSD
    • Blast Overpressure
  • Clinical Tools
    • Observational Tools
    • Imaging
    • Neurocognitive
  • Biomarkers 1
  • Biomarkers 2
  • microRNA
  • Neurodegenerative Dx
    • Neuro Dx
    • Our Staff
    • Contact Us
    • Blog

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Neuropsychological Assessment in Mild Traumatic Brain Injury (mTBI)

Neuropsychological testing is used to assess cognitive domains such as attention, memory, processing speed, executive function, and reasoning in individuals with suspected traumatic brain injury (TBI). These assessments are most commonly indicated in complex or prolonged concussion, where symptoms persist beyond expected recovery timelines or where return-to-work, return-to-play, or medico-legal decisions are required¹.

Performance on neuropsychological tests is influenced by numerous non-injury-related factors, including prior concussion history, depression or anxiety, sleep disturbance, medication use, fatigue, pain, and motivation. These factors can either prolong recovery or mimic concussion symptoms, complicating interpretation of results².


Baseline and Post-Injury Testing

In elite sport and research settings, neuropsychological testing is often performed pre-season to establish an individual baseline, allowing post-injury performance to be compared against the athlete’s own normative function rather than population averages³. This approach is widely used in professional leagues and collegiate sport.

However, baseline testing introduces its own limitations. Performance can be affected by effort, environmental conditions, and learning effects. In some cases, individuals may intentionally underperform at baseline (“sandbagging”), reducing the sensitivity of post-injury comparisons⁴. Even when conducted appropriately, neuropsychological tests remain indirect measures of brain function rather than direct indicators of biological injury.


Subjectivity and Psychometric Limitations

While neuropsychological testing provides valuable clinical information, it is predominantly behavioural and performance-based, meaning that changes over time may not reliably reflect underlying biological recovery. Many commonly used concussion tools and symptom scales were adopted into widespread use before comprehensive validation, and their reliability, sensitivity, and specificity vary considerably⁵.

No single neuropsychological or sideline assessment tool is universally accepted as the “gold standard” for concussion diagnosis or recovery tracking. Contemporary consensus statements emphasise that these tools should be used as part of a multimodal clinical assessment, rather than in isolation⁶.


Emerging and Adjunctive Tools

To address these limitations, several adjunctive approaches are being explored or implemented alongside traditional neuropsychological testing:

  • Computerised cognitive testing platforms (e.g. ImPACT, CNS Vital Signs) for standardised serial assessment
  • Vestibular–ocular motor screening (VOMS) to assess balance and oculomotor dysfunction
  • Digital symptom tracking and wearable technologies to capture activity, sleep, and physiologic data
  • Objective biomarkers, including blood-based markers and molecular signatures, to provide biological context to cognitive findings⁷,⁸

These approaches aim to improve diagnostic confidence, reduce reliance on subjective reporting, and better capture sub-concussive and cumulative injury.


Role in Management and Rehabilitation

Neuropsychologists play an important role in education, monitoring, and rehabilitation following concussion. Interventions may include psychoeducation regarding normal recovery, cognitive behavioural therapy (CBT) for maladaptive symptom focus, and structured cognitive rehabilitation in cases of persistent impairment¹.

Repeat neuropsychological testing can be useful to document functional improvement over time, but results must be interpreted cautiously and in conjunction with clinical findings, symptom evolution, and—where available—objective biological measures.


Current Best Practice

Modern guidelines emphasise that each concussion should be managed individually, using as much objective information as feasible, and interpreted within the context of the individual’s baseline, medical history, and recovery trajectory⁶. Neuropsychological testing remains a valuable but incomplete component of concussion assessment, reinforcing the need for complementary objective tools that can more directly reflect underlying brain injury.

References

  1. Silverberg ND, Iverson GL. Etiology of the post-concussion syndrome. Phys Med Rehabil Clin N Am. 2011;22(4):709–722.
  2. McCrory P, Meeuwisse W, Dvořák J, et al. Consensus statement on concussion in sport—6th International Conference. Br J Sports Med. 2023;57(11):695–711.
  3. Broglio SP, Ferrara MS, Macciocchi SN, Baumgartner TA, Elliott R. Test–retest reliability of computerized concussion assessment programs. J Athl Train. 2007;42(4):509–514.
  4. Bailey CM, Echemendia RJ, Arnett PA. The impact of motivation on neuropsychological test performance. Arch Clin Neuropsychol. 2006;21(3):241–248.
  5. Randolph C, McCrea M, Barr WB. Is neuropsychological testing useful in the management of sport-related concussion? J Athl Train. 2005;40(3):139–152.
  6. Patricios J, Ardern C, Hislop M, et al. Implementation of concussion management strategies. Br J Sports Med. 2023;57(12):752–760.
  7. Iverson GL, Gardner AJ, McCrory P, et al. A critical review of concussion assessment tools. Br J Sports Med. 2022;56(8):439–446.
  8. Di Pietro V, Porto E, Ragusa M, et al. MicroRNAs as novel biomarkers for traumatic brain injury. J Neurotrauma. 2018;35(18):1–14.

Copyright © 2026 GLIA Diagnostics - All Rights Reserved.

Powered by

This website uses cookies.

Some regional laws require website owners to inform visitors of cookie tracking.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept